All Type of News
KFDA approves new treatment option for late-stage breast cancer
The Korea Food and Drug Administration approved last Friday Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease...
Pediatric diseases on gradual rise
Diseases among the pediatric population aged 6 years or lower are rising, a state-run agency report said recently.
According to the National Health Insurance Corporation (NHIC), a ministry affiliate, the number of ...
Hanmi’s Viagra generic sees huge sales spike on growing demand
Sales of Hanmi Pharmaceutical’s Viagra generic drug ‘Palpal tablets’ are on a roll thanks to their aggressive marketing campaign and pricing advantage over the American pharmaceutical firm Pfizer’s original drug, acco...
Pharmaceutical firms brace for effects of gov’t-imposed price cuts
This is likely to be a grueling year for Korean pharmaceutical companies as they feel the brunt of government-imposed price cuts.
Last April, the Ministry of Health and Welfare lowered the prices of 6,506 different...
Drug makers spend 35% of revenue on promotion
Domestic drug firms have still spent a larger proportion of their annual revenue on promotion to boost sales amid worsening profitability due to the government-mandated cuts in drug prices.
Details of drug company ...
Multinational firms increase market share
With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.
According to IMS data, Do...
Will Revlimid be covered by health insurance?
Will myeloma patients be able to get cheaper and better drugs this year? Now all eyes are on the Health Insurance Review and Assessment Service (HIRA) committee's decision on the reimbursement of Revlimid, a new drug ...
Green Cross becomes largest shareholder of Innocell
Green Cross Corp. recently purchased 23.43 percent in shares of Innocell, a Korean cell therapeutics company.
The company announced Thursday in a regulatory filing that it acquired Innocell as the largest sharehold...
Pharmaceutical firms’ profits tumble in 2Q
Local drug companies saw a substantial setback in their performance in their fiscal second quarter with operating profits more than halved due to fallout from the government-mandated cuts in drug prices in April.
A...
EZMedicom keeps top spot in domestic hospital logistics service
EZMedicom, a medical E-commerce leader in Korea, maintained its dominant position in the local hospital logistics service market valued at 1.2 trillion won.
The company said in a regulatory filing Tuesday that its ...
